Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 68382-824

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 68382-824). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (203f5024 62db 45d6 97b4 Db723679dc5c 01)

Chemical structure diagram of the active ingredient Sevelamer carbonate, showing polymeric components with amine and hydroxyl groups along with bicarbonate ions indicated as part of the structure.*

FDA Label Image

Image (203f5024 62db 45d6 97b4 Db723679dc5c 02)

A forest plot showing subgroup analyses comparing the effects of Sevelamer carbonate versus placebo. Subgroups are based on screening body surface area, baseline serum phosphorus levels, age, and dialysis status, with plotted mean differences and 95% confidence intervals indicating favorability toward Sevelamer carbonate or placebo.*

FDA Label Image

Image (203f5024 62db 45d6 97b4 Db723679dc5c 03)

A line plot comparing percentage of patients with a reduction of serum phosphorus by at least 2x, contrasting Sevelamer Hydrochloride and an Active Control. The x-axis displays reduction in serum phosphorus (mg/dL) from -4 to 8 and the y-axis shows percentage of patients from 0 to 100%.*

FDA Label Image

Image (203f5024 62db 45d6 97b4 Db723679dc5c 04)

A line graph depicting phosphorus change from baseline over a 52-week study period. The horizontal axis represents study weeks, while the vertical axis shows phosphorus change. Two treatment groups are compared: Sevelamer Hydrochloride and an Active-Control, shown as black circles and red squares, respectively, with phosphorus levels decreasing and stabilizing over time.*

FDA Label Image

Image (203f5024 62db 45d6 97b4 Db723679dc5c 05)

Label for Sevelamer Carbonate Tablets 800 mg, film-coated oral tablets. The label shows the product name, strength, and a depiction of the gray, oval tablet with imprint "824." It includes the quantity of 270 tablets, the prescription only status, and manufacturer information from Cadila Healthcare Ltd. and distributor Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.